SEC Form 4 · accession 0001638599-16-001083
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony J Maddaluna
Director
Period of report
Jun 15, 2016
Accepted (ET)
Jun 16, 2016 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 15, 2016 | A | 3,036 | $14.82 | A | 5,890 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares issued to the reporting person pursuant to the Albany Molecular Research, Inc. Third Amended 2008 Stock Option and Incentive Plan in lieu of a cash payment.